Literature DB >> 6212595

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.

C Thornsberry, A L Barry, R N Jones, C N Baker, R E Badal.   

Abstract

Cefoperazone is a new cephalosporin with a very wide spectrum of activity, including activity against Pseudomonas aeruginosa. It has less activity on enterococci and Acinetobacter. Of the 459 selected bacterial strains tested in this study, only 1.5% (7 strains and 6 genera) had minimum inhibitory concentrations of greater than or equal to 128 micrograms/ml. For a minimum inhibitory concentration breakpoint of less than or equal to 32 micrograms/ml (susceptible), we recommend that the disk diffusion test be done with a 75-micrograms disk and breakpoints of greater than or equal to 18 mm for susceptible, 15 to 17 mm for intermediate, and less than or equal to 14 mm for resistant. Diffusion tests using these criteria yielded only 1.1% very major or major errors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6212595      PMCID: PMC272188          DOI: 10.1128/jcm.15.5.769-776.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparative pharmacokinetics of cefoperazone and cefotaxime.

Authors:  H Lode; B Kemmerich; P Koeppe; D Belmega; H Jendroschek
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

2.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

3.  Cefoperazone: absorption, excretion, distribution, and metabolism.

Authors:  K Shimizu
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

4.  Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.

Authors:  C Thornsberry; C N Baker; A L Barry; R N Jones
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

5.  Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.

Authors:  L Balant; P Dayer; M Rudhardt; A F Allaz; J Fabre
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

6.  Single-dose pharmacokinetics of cefoperazone following intravenous administration.

Authors:  W A Craig
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

7.  Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; E H Gerlach; H M Sommers
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

8.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

9.  Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.

Authors:  N V Jacobus; F P Tally; M Barza; S L Gorbach
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

10.  Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

View more
  6 in total

1.  Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  D J Hardy; A L Barry; P C Fuchs; E H Gerlach; J C McLaughlin; M A Pfaller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms.

Authors:  R J Zabransky; E Randall; V L Sutter; R J Birk; G Westenfelder; J Emmerman; A T Ghoneim
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion.

Authors:  Ming Ma; Mostafa E Rateb; Qihui Teng; Dong Yang; Jeffrey D Rudolf; Xiangcheng Zhu; Yong Huang; Li-Xing Zhao; Yi Jiang; Xiuling Li; Christoph Rader; Yanwen Duan; Ben Shen
Journal:  J Nat Prod       Date:  2015-09-03       Impact factor: 4.050

4.  Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.

Authors:  G Kronvall
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

5.  Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.

Authors:  R N Jones; T L Gavan; A L Barry; C Thornsberry; D L Gibbs
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

6.  Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.

Authors:  C Thornsberry; R N Jones
Journal:  Drugs       Date:  1981       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.